← Back to Search
Behavioral Intervention
Mind Body Intervention for Post-COVID Syndrome
Boston, MA
N/A
Recruiting
Led By Michael Donnino, MD
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Symptoms attributed only to COVID-19 and not to known comorbid disease (e.g., other infections, cancer, etc)
A somatic symptom score ≥ 10 on the SSS-8 questionnaire with involvement of at least 3 domains
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 weeks, 8 weeks, 13 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to see if a mind-body intervention can help people with Long COVID symptoms. They will compare the effectiveness of this intervention with usual care and another mind-body intervention. The study will also look
See full description
Who is the study for?
This trial is for adults over 18 who've had COVID-19, as confirmed by a test, and are now experiencing Long COVID symptoms. They should have these symptoms on most days for at least three months and be willing to try a mind-body intervention. People with other serious diseases causing similar symptoms can't join.Check my eligibility
What is being tested?
The study tests if a specific mind-body intervention can reduce the physical symptoms of Long COVID compared to usual care or another mind-body technique. It also looks at whether it helps improve daily functioning.See study design
What are the potential side effects?
Mind-body interventions typically involve low-risk activities like meditation or yoga, which may cause mild discomfort or muscle soreness but generally do not lead to severe side effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My symptoms are only due to COVID-19, not any other illness.
show original
Select...
I experience significant physical symptoms affecting at least three areas of my body.
show original
Select...
I am 18 years old or older.
show original
Select...
I have had symptoms for at least 3 days a week for the past 3 months.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 4 weeks, 8 weeks, 13 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 weeks, 8 weeks, 13 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Somatic Symptom Score-8 (SSS-8)
Secondary study objectives
End of study measurements
Fatigue Severity Scale (FSS)
Generalized Anxiety Disorder form 7 (GAD-7)
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Mind Body Intervention #1Experimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention
Group III: Mind Body Intervention #2Active Control1 Intervention
Find a Location
Closest Location:Beth Israel Deaconess Medical Center· Boston, MA· 644 miles
Who is running the clinical trial?
Beth Israel Deaconess Medical CenterLead Sponsor
869 Previous Clinical Trials
12,930,743 Total Patients Enrolled
7 Trials studying COVID-19
18,871 Patients Enrolled for COVID-19
Michael Donnino, MDPrincipal InvestigatorBeth Israel Deaconess Medical Center
7 Previous Clinical Trials
442 Total Patients Enrolled
1 Trials studying COVID-19
23 Patients Enrolled for COVID-19